戻る
Regeneron Pharmaceuticals Inc (REGN)価格
REGN 株価推移チャート
REGN 収入
Regeneron Pharmaceuticals Inc
$733.04
-1.19%
$-8.87
終値： Jan 16, 16:00:00 GMT-5
$736
0.4%
$2.96
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$741.92
始値
$749.09
当日レンジ
$726.43 - $749.09
52週レンジ
$476.49 - $821.11
取引高
1.6M
平均取引高
991.1K
1株当たり利益(TTM)
41.78
配当利回り
--
時価総額
$77.3B
REGNとは何ですか？
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. The company is headquartered in Tarrytown, New York and currently employs 15,106 full-time employees. The firm invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The firm is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.